company
Ascend Laboratories, LLC
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-06-17Ascend Laboratories, LLC — Class II recall: Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle…
- fda_recall · drug_recall2026-06-10Ascend Laboratories, LLC — Class II recall: Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle,…
- fda_recall · drug_recall2026-05-20Ascend Laboratories, LLC — Class II recall: Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25…
Frequently asked questions
- How many FDA warning letters has Ascend Laboratories, LLC received?
- Argus HQ has not recorded an FDA warning letter for Ascend Laboratories, LLC in our current dataset.
- What FDA recalls has Ascend Laboratories, LLC issued?
- Argus HQ has recorded 3 FDA recalls tied to Ascend Laboratories, LLC.
- Is Ascend Laboratories, LLC FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 3 recalls, and 0 approval records for Ascend Laboratories, LLC. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.